ASSISTANT PROFESSOR, MEDICAL ONCOLOGY FROM 01.08.2022 TO 17.04.2023.

Certificates

Fellow – MCCR, MSMO

Memberships

2014 – Present: Life Member, Association of Radiation Oncologists of India (AROI), ID: LM 2244.

2003 – Selected for National Talent Search Examination Scholarship

2005 – Secured 49^th rank in Engineering and Medical Common Entrance Test (EAMCET) in Andhra Pradesh

2013 – Secured all-India 80^th rank in MD/MS entrance exam conducted by All India Institute of Medical Sciences, New Delhi

2016 – Awarded  1^st  prize in the Quiz on Head and Neck Oncology conducted by Indian College of Radiation Oncology (ICRO)

2019 – Awarded 1^st prize in Mumbai Hematology Group Quarterly Conference for Presenation on Acute Leukemia with FGFR Translocation

2020 – Presented TMH Data on Young Breast Cancer in TAYCON 2020 conference and Women’s Cancer Initiative (WCI) Conference

2020 – Wrote a Chapter titled “Chemotherapy related Oral Complications and Management” For textbook of Dental Sciences

2021 – Wrote a Chapter on “Role of PDL-1 in NSCLC and other solid tumors” for TMH EBM book 2021

(1–6)

1. Anaplastic hemangiopericytoma of eyelid: An unusual location , J Cancer Res Ther. 2017 Jan-Mar;13(1):145-147
2. Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience. Journal of Clinical Oncology 2018 36:4_suppl, 857-857
3. Pattern of microbial organisms in radiation induced mucositis and dermatitis in head and neck squamous cell carcinoma (HNSCC) treated with radiation (RT)/chemo radiation (CTRT). Journal of Clinical Oncology 2014 32:31_suppl, 210-210
4. Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Jain S, Talreja VT, Kapoor A, Kumar Singh G, Khaddar S, Gupta K, Rathinasamy N, Srinivas S, Agrawal A, Ventrapati P, Prabhash K. A real-world data of Immune checkpoint inhibitors in solid tumors from India. 
5. Cancer Med. 2021 Feb 16. doi: 10.1002/cam4.3617. Epub ahead of print. PMID: 33591635
6. Bondili SK, Bagal B, Zawar A, Ventrapati P, Thorat J, Gokarn A, et al. Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma—Experience From a Tertiary Care Cancer Center. JCO Glob Oncol. 2021 Dec;(7):361–7.
7. Ramaswamy A, Kothari R, Desouza A, Gupta T, Bairwa S, Kapoor A, et al. Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX. South Asian J Cancer. 2019 Jul;08(03):160–5.
8. Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, et al. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med. 2021;10(5):1525–34.
9. Pradeep V. Time for cancer to be designated a notifiable disease in India. Cancer Res Stat Treat. 2021 Jan 1;4(1):153.
10.  Bajpai J, Ventrapati P, Joshi S, Wadasadawala T, Rath S, Pathak R, et al. Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. The Breast. 2021 Dec 1;60:177–84.
11. Ventrapati P. Old targets, new bullets, nursing fresh hope. Cancer Res Stat Treat. 2021 Oct 1;4(4):788.